Qiagen N.V.

Qiagen N.V.

Qiagen N.V.

Overview
Date Founded

1996

Headquarters

Hulsterweg 82,Venlo, Limburg 5912 PL

Type of Company

Public

Employees (Worldwide)

5,610

Industries

Industrial Machinery & Manufacturing
Wholesale: Industrial Products & Manufacturing
Hospitals & Patient Services

Company Description

QIAGEN NV is a holding company, which engages in the provision of sample and assay technology to transform biological samples into valuable molecular insights. It offers bioinformatics, molecular diagnostics, next-gen sequencing, and genomic services. The company was founded by Detlev H. Riesner and Metin Colpan on April 29, 1996 and is headquartered in Venlo, the Netherlands.

Contact Data
Trying to get in touch with decision makers at Qiagen N.V.? Subscribe today to access their professional contact information and receive a one time promotion of free Contact Data credits!
Executives & Employees

Co-Founder

Chief Executive Officer & Managing Director

Chief Financial Officer

President, Asia-Pacific

Senior Vice President, Head of Molecular Diagnostics Business Area & Corporate Business Development

Senior Vice President-Global Sales & Managing Director

Senior Vice President, Life Science Business Area

Senior Vice President, Head of Global Operations

Senior Vice President, Head of Human Resources

Vice President, Head of Global Treasury & Insurances

Supervisory Board

Former Chief Financial Officer at Deutsche Post AG

Laurence Joseph Dineen Chair in Leukemia Research at Memorial Sloan-Kettering Cancer Center

Industrial Partner for IT, Digital & Media, Healthcare & Pharma at Rantum Capital Management GmbH

Member-Sports Board at The University of Nottingham

Co-Executive Director, Institute for Genomic Medicine at Nationwide Children's Hospital

President & Chief Executive Officer at Voith GmbH

Paths to Qiagen N.V.
Potential Connections via
Relationship Science
You
Qiagen N.V.
Owners & Shareholders
Details Hidden

DKCM invests client assets using a variety of arbitrage and other event-driven strategies, including risk arbitrage transactions and investments in financially distressed companies. The firm's primary investment strategies include distressed investing, mergers and acquisitions (or risk) arbitrage, long/short equities, and convertible and volatility arbitrage. As distressed investment opportunities are identified, they are subjected to rigorous, fundamental, bottom-up analysis.

Details Hidden

FCM seeks investments across asset classes and around the world through a process of bottom-up fundamental research and analysis emphasizing capital preservation. Their investment strategies include Credit Investments, Long/Short Equity, Merger Arbitrage, Risk Arbitrage, Real Estate Investments and Direct Investments. Investment ideas compete for capital based on in-depth, critical assessment of specific risks and rewards. Risk is monitored and managed through rigorous and thorough analysis of each investment and, at the portfolio level, through risk management analytics and overlay and tail-risk hedging.

Details Hidden

Eleva Capital actively invests in European equities. They manges three UCITS funds namely: Eleva European Selection, Eleva Euroland Selection and Eleva Absolute Return Europe. Both Eleva European Selection and Eleva Euroland Selection aims to achieve superior long-term risk adjusted return, has medium-term time horizon and invest using bottom-up stock-picking approach. Eleva Absolute Return Europe aims to achieve an absolute return over the medium-term through capital growth. It invests in equity related securities on both a long and short basis and has a differentiated and disciplined bottom-up investment philosophy complemented by a macroeconomic overlay to support sector positioning.

Recent Transactions
Details Hidden

Thermo Fisher Scientific, Inc. purchases Qiagen N.V.

Details Hidden

Calibrescientific, Inc. purchases QIAGEN Canada, Inc. from Qiagen N.V.

Details Hidden

Qiagen N.V. purchases Parsagen Diagnostics, Inc. from LRVHealth Ventures LLC, LaunchCapital LLC, Mass Medical Angels LLC, Kahm Capital LLC

Transaction Advisors
Accountant

Advised onQiagen NV /Synthetic DNA Business/ /Management purchases Qiagen NV /Synthetic DNA Business from Qiagen N.V.

Legal Advisor

Advised onQiagen N.V. purchases QIAGEN Marseille SA

Legal Advisor

Advised onThermo Fisher Scientific, Inc. purchases Qiagen N.V.

Chair of the Securities Practice Group

Advised onThermo Fisher Scientific, Inc. purchases Qiagen N.V.

Legal Advisor

Advised onThermo Fisher Scientific, Inc. purchases Qiagen N.V.

Legal Advisor

Advised onThermo Fisher Scientific, Inc. purchases Qiagen N.V.

Advisors & Consultants
Advisor

Co-Founder at GHO Capital Partners LLP

Managing Partner at MinterEllison

Consultant

Co-Founder at QBM Cell Science, Inc.

Clients

NeoGenomics, Inc. is a clinical laboratory company, which engages in cancer genetics diagnostic testing and pharma services. It operates through the Clinical Services and Pharma Services segments. The Clinical Services segment offers cancer testing services to community-based pathologists, hospitals, academic centers, and oncology groups. The Pharma Services segment focuses on supporting pharmaceutical firms in drug development programs by supporting various clinical trials. The company was founded by Michael T. Dent on October 29, 1998 and is headquartered in Fort Myers, FL.

Government of the United Kingdom is the central government of the United Kingdom of Great Britain and Northern Ireland.The government is led by the Prime Minister, who selects all the remaining ministers. The prime minister and the other most senior ministers belong to the supreme decision-making committee, known as the Cabinet.

Invitae Corp. engages in the provision of genetic information into mainstream medical practice. It includes comprehensive panels for hereditary conditions in cancer, cardiology, neurology, pediatric, and rare diseases. The company was founded by Randal W. Scott and Sean E. George on January 13, 2010 and is headquartered in San Francisco, CA.

Key Stats and Financials As of 2020
Market Capitalization
$10.7B
Total Enterprise Value
$13.7B
Earnings Per Share
$1.53
Revenue
$1.87B
Total Equity
$2.8B
Net Profit
$359M
EBITDAMargin
38.46%
Total Debt
$2.03B
EBITDA
$719M
Enterprise Value / Sales
7.32x
Enterprise Value EBITDAOperating
18.89x
TEVNet Income
38.13x
Debt TEV
0.15x
Three Year Compounded Annual Growth Rate Of Revenue
9.68%
Investments
Details Hidden

Protagen AG specializes in the development of novel diagnostic and companion diagnostic tests. Its products and services include GMP analyses, protein identification and analyses, proteome studies, UNIchip, clone and array, Bio-IT, Modiro as well as ProteinScape and Solver. The company was founded by Stefan Müllner, Helmut E. Meyer, Petra Weingarten and Martin Blüggel in 1997 and is headquartered in Dortmund, Germany.

Details Hidden

Curetis NV engages in the manufacture, research and development, and commercialization of molecular microbiology solutions. It offers unyvero platform, which comprsises of the unyvero system with the A50 analyzer at its core, proprietary software, and single-use, application-specific cartridges. The company was founded by Johannes Bacher, Gerd Luedke and Andreas Boos in August 2007 and is headquartered in Holzgerlingen, Germany.

Details Hidden

Exosome Diagnostics, Inc. develops and commercializes biofluid-based diagnostics to deliver personalized precision healthcare that improves lives. Its novel exosome-based technology platform can yield comprehensive and dynamic molecular insights to transform how cancer and other serious diseases are detected, diagnosed, treated and monitored. The company was founded by Wayne D. Comper, Harvey J. Barnett and James R. McCullough and is headquartered in Waltham, MA.

Suppliers
Precision System Science Co., Ltd. Medical Products & Equipment | Matsudo, Japan

Precision System Science Co., Ltd. engages in the development, manufacture and sale of automated systems, physicochemical instruments, and reagents. It operates through the following segments: Instruments, Reagent Kits & Consumable, Maintenance, and Customized Products. The Instruments segment offers equipment for automatic DNA (Deoxyribonucleic Acid) extraction for laboratories and clinical institutions that includes immunochemical luminescent measuring systems and equipment for specimen pretreatment. The Reagent Kits & Consumable segment consists of PSS (Precision System Science) brand reagent for sample preparation and exclusively designed plastic consumables for PSS instruments. The Maintenance segment engages in the systems maintenance and sales of spare parts. The Customized Products segment sells customized automation systems and develops systems in accordance with customer specifications. The company was founded on July 17, 1985 and is headquartered in Matsudo, Japan.

MDxHealth SA Biotechnology | Herstal, Belgium

MDxHealth SA engages in the development and commercialization of molecular diagnostic products for personalized cancer treatment. It operates through the following geographical segments: United States of America, The Netherlands, Belgium, Spain, Poland, Italy, Rest of EU, and Rest of the World. It offers ConfirmMDx, SelectMDx, AssureMDx, InformMDx, SelectMDx, and MonitorMDx. The company was founded by Herman Spolders and Philip S. Devine on January 10, 2003 and is headquartered in Herstal, Belgium.

Altium Ltd. Computer Software | Chatswood, Australia

Altium Ltd. engages in developing and selling of computer software for the design of electronic products. It operates through the following segments: Board and Systems, Micro-Controllers and Embedded Systems, and Electronic Parts, Search and Discovery. The Board and Systems segment includes results from PCB business for the americas, EMEA, asia pacific and emerging Markets regions, as well as other products sold through partner channels. The Micro-Controllers and Embedded Systems segment comprises of results from tasking sales, operations and research and development. The Electronic Parts, Search and Discovery segment includes the results from Octopart and Upverter. The company was founded by Nicholas Martin in 1985 and is headquartered in Chatswood, Australia.

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Qiagen N.V.. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Qiagen N.V.'s profile does not indicate a business or promotional relationship of any kind between RelSci and Qiagen N.V..